InsiderTrades.com logo
Ilya Goldshleger net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Ilya Goldshleger Biography and Net Worth

Insider of RxSight

Dr. Goldshleger joined RxSight, Inc. as the Vice President, Engineering and has served as our Chief Operating Officer since June 2019. Dr. Goldshleger joined RxSight in September 2015 as the Vice President of Engineering and was responsible for the development and engineering of the LAL and LDD system and its accessories. Prior to joining RxSight, Dr. Goldshleger held various management roles at Alcon LenSx, Inc. from 2010 to 2015, last serving as Director, R&D Optics and Diagnostics, and held various roles in research and development at LenSx Lasers, Inc. from October 2008 to its acquisition by Alcon, Inc. (NYSE:ALC) in August 2010. Dr. Goldshleger received a Master of Science in Physics and Mathematics from the Moscow Institute of Physics and Technology and a Ph.D. in Chemical Physics from the Russian Academy of Sciences.

What is Ilya Goldshleger's net worth?

The estimated net worth of Ilya Goldshleger is at least $594,823.68 as of November 29th, 2024. Goldshleger owns 42,246 shares of RxSight stock worth more than $594,824 as of April 13th. This net worth estimate does not reflect any other assets that Goldshleger may own. Additionally, Goldshleger receives a salary of $761,460.00 as Insider at RxSight. Learn More about Ilya Goldshleger's net worth.

How old is Ilya Goldshleger?

Goldshleger is currently 49 years old. There are 3 older executives and no younger executives at RxSight. The oldest executive at RxSight is Ms. Shelley B. Thunen, Chief Financial Officer, who is 70 years old. Learn More on Ilya Goldshleger's age.

What is Ilya Goldshleger's salary?

As the Insider of RxSight, Inc., Goldshleger earns $761,460.00 per year. There are 3 executives that earn more than Goldshleger. The highest earning executive at RxSight is Dr. Ronald M. Kurtz M.D., President, CEO & Director, who commands a salary of $1,210,000.00 per year. Learn More on Ilya Goldshleger's salary.

How do I contact Ilya Goldshleger?

The corporate mailing address for Goldshleger and other RxSight executives is , , . RxSight can also be reached via phone at 949-521-7830 and via email at ir@rxsight.com. Learn More on Ilya Goldshleger's contact information.

Has Ilya Goldshleger been buying or selling shares of RxSight?

Ilya Goldshleger has not been actively trading shares of RxSight over the course of the past ninety days. Most recently, Ilya Goldshleger sold 3,105 shares of the business's stock in a transaction on Friday, November 29th. The shares were sold at an average price of $46.08, for a transaction totalling $143,078.40. Following the completion of the sale, the insider now directly owns 42,246 shares of the company's stock, valued at $1,946,695.68. Learn More on Ilya Goldshleger's trading history.

Who are RxSight's active insiders?

RxSight's insider roster includes Julie Andrews (Director), Juliet Bakker (Director), Jesse Corley (Director), Tamara Fountain (Director), Ilya Goldshleger (Insider), Ilya Goldshleger (Insider), M Kurtz (CEO), William Link (Director), Shweta Maniar (Director), Shelley Thunen (CFO), Robert Warner (Director), and Eric Weinberg (Insider). Learn More on RxSight's active insiders.

Are insiders buying or selling shares of RxSight?

In the last year, RxSight insiders bought shares 2 times. They purchased a total of 12,554 shares worth more than $549,098.81. In the last year, insiders at the sold shares 28 times. They sold a total of 160,951 shares worth more than $8,269,376.44. The most recent insider tranaction occured on March, 12th when Director Tamara Fountain sold 7,000 shares worth more than $179,970.00. Insiders at RxSight own 9.4% of the company. Learn More about insider trades at RxSight.

Information on this page was last updated on 3/12/2025.

Ilya Goldshleger Insider Trading History at RxSight

Ilya Goldshleger Buying and Selling Activity at RxSight

This chart shows Ilya Goldshleger's buying and selling at RxSight by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$2M-$1M$0$1M$2MTotal Insider BuyingTotal Insider Selling

RxSight Company Overview

RxSight logo
RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Read More

Today's Range

Now: $14.08
Low: $13.50
High: $14.56

50 Day Range

MA: $25.63
Low: $14.08
High: $34.26

2 Week Range

Now: $14.08
Low: $13.50
High: $66.54

Volume

1,102,327 shs

Average Volume

603,910 shs

Market Capitalization

$570.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.26